News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,763 Results
Type
Article (86049)
Company Profile (651)
Press Release (753063)
Section
Business (232466)
Career Advice (4123)
Deals (39702)
Drug Delivery (127)
Drug Development (90841)
Employer Resources (195)
FDA (18035)
Job Trends (17303)
News (395986)
Policy (39664)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2983)
Academic (1)
Accelerated approval (3)
Adcomms (28)
Allergies (83)
Alliances (56711)
ALS (82)
Alzheimer's disease (1430)
Antibody-drug conjugate (ADC) (124)
Approvals (17997)
Artificial intelligence (248)
Autoimmune disease (13)
Automation (14)
Bankruptcy (399)
Best Places to Work (12618)
BIOSECURE Act (21)
Biosimilars (104)
Biotechnology (448)
Bladder cancer (56)
Brain cancer (25)
Breast cancer (243)
Cancer (1896)
Cardiovascular disease (153)
Career advice (3524)
Career pathing (32)
CAR-T (146)
Cell therapy (417)
Cervical cancer (14)
Clinical research (72694)
Collaboration (748)
Compensation (390)
Complete response letters (29)
COVID-19 (2838)
CRISPR (38)
C-suite (189)
Cystic fibrosis (103)
Data (1743)
Decentralized trials (2)
Denatured (41)
Depression (43)
Diabetes (229)
Diagnostics (6833)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (112)
Drug pricing (113)
Drug shortages (27)
Duchenne muscular dystrophy (67)
Earnings (95606)
Editorial (32)
Employer branding (25)
Employer resources (166)
Events (128542)
Executive appointments (611)
FDA (19031)
Featured Employer (69)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (661)
Gene editing (97)
Generative AI (25)
Gene therapy (297)
GLP-1 (771)
Government (5087)
Grass and pollen (4)
Guidances (44)
Healthcare (20832)
Huntington's disease (24)
IgA nephropathy (22)
Immunology and inflammation (103)
Indications (24)
Infectious disease (2962)
Inflammatory bowel disease (139)
Inflation Reduction Act (11)
Influenza (45)
Intellectual property (72)
Interviews (811)
IPO (17771)
IRA (47)
Job creations (5183)
Job search strategy (2860)
Kidney cancer (10)
Labor market (30)
Layoffs (522)
Leadership (19)
Legal (10080)
Liver cancer (74)
Lung cancer (280)
Lymphoma (123)
Machine learning (2)
Management (64)
Manufacturing (274)
MASH (61)
Medical device (14508)
Medtech (14513)
Mergers & acquisitions (22302)
Metabolic disorders (636)
Multiple sclerosis (63)
NASH (23)
Neurodegenerative disease (84)
Neuropsychiatric disorders (29)
Neuroscience (1901)
NextGen: Class of 2025 (7664)
Non-profit (5075)
Northern California (2253)
Now hiring (36)
Obesity (350)
Opinion (263)
Ovarian cancer (64)
Pain (76)
Pancreatic cancer (71)
Parkinson's disease (124)
Partnered (19)
Patents (185)
Patient recruitment (82)
Peanut (50)
People (64830)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (22431)
Phase II (31574)
Phase III (23774)
Pipeline (828)
Podcasts (114)
Policy (118)
Postmarket research (3551)
Preclinical (10057)
Press Release (72)
Prostate cancer (88)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (365)
Real estate (7381)
Recruiting (74)
Regulatory (26445)
Reports (54)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (1)
RSV (38)
Schizophrenia (68)
Series A (123)
Series B (73)
Service/supplier (27)
Sickle cell disease (55)
Southern California (1931)
Special edition (17)
Sponsored (33)
Startups (4284)
State (2)
Stomach cancer (12)
Supply chain (58)
The Weekly (72)
United States (20456)
Vaccines (725)
Venture capitalists (35)
Webinars (13)
Weight loss (261)
Women's health (35)
Worklife (16)
Date
Today (187)
Last 7 days (856)
Last 30 days (3063)
Last 365 days (36537)
2025 (5864)
2024 (37577)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1268)
Alabama (55)
Alaska (7)
Arizona (245)
Arkansas (13)
Asia (49799)
Australia (8780)
California (5235)
Canada (1783)
China (440)
Colorado (240)
Connecticut (250)
Delaware (118)
Europe (114051)
Florida (757)
Georgia (180)
Hawaii (1)
Idaho (64)
Illinois (534)
India (23)
Indiana (287)
Iowa (8)
Japan (129)
Kansas (106)
Kentucky (25)
Louisiana (10)
Maine (64)
Maryland (829)
Massachusetts (4077)
Michigan (214)
Minnesota (368)
Mississippi (2)
Missouri (73)
Montana (30)
Nebraska (26)
Nevada (56)
New Hampshire (64)
New Jersey (1479)
New Mexico (30)
New York (1477)
North Carolina (1005)
North Dakota (8)
Northern California (2253)
Ohio (183)
Oklahoma (14)
Oregon (44)
Pennsylvania (1168)
Puerto Rico (7)
Rhode Island (25)
South America (1649)
South Carolina (13)
South Dakota (1)
Southern California (1931)
Tennessee (84)
Texas (765)
Utah (159)
Virginia (129)
Washington D.C. (59)
Washington State (518)
West Virginia (3)
Wisconsin (47)
839,763 Results for "ocean bio chem inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LG Chem and Acies Bio Collaborate to Advance Sustainable Production of Chemicals
December 5, 2024
·
4 min read
Press Releases
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development
February 10, 2025
·
8 min read
Press Releases
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
January 29, 2025
·
8 min read
Press Releases
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
November 25, 2024
·
5 min read
Press Releases
GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
February 10, 2025
·
9 min read
Press Releases
BioFlyte Awarded SBIR Phase I Contract by U.S. Air Force to Advance its Aerosol Chem/Biothreat Detection and Identification Technology for Critical Infrastructure
February 4, 2025
·
3 min read
Press Releases
AVEO Oncology, an LG Chem company, Presents Two Posters for Tivozanib at the 2025 ASCO GU Meeting
February 19, 2025
·
9 min read
Genetown
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
Ocean Biomedical, Inc., announced that on April 18, 2024, it received a notice from The Nasdaq Stock Market LLC stating that because the Company has not yet filed its Annual Report on Form 10-K for the period ended December 31, 2023, the Company is not in compliance with Nasdaq Listing Rule 5250, which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.
April 24, 2024
·
5 min read
Drug Development
LG Chem company and AVEO Oncology Announce LG Chem’s First Proprietary Anti-Cancer Compound enters Phase 1 Clinical Study, Dosing Initiated in the U.S.
LG Chem and AVEO Oncology, an LG Chem company, announced that it has enrolled the first patient in the United States for a Phase 1 clinical study of LB-LR1109, LG Chem’s first proprietary anti-cancer investigational drug candidate.
June 13, 2024
·
4 min read
Pharm Country
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
Ocean Biomedical (NASDAQ: OCEA ) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his malaria therapeutic antibody discoveries, targeted to both prevent malaria infection and treat severe malaria.
May 16, 2024
·
7 min read
1 of 83,977
Next
